BiomX Inc. Files S-1 Registration Statement
Ticker: PHGE · Form: S-1 · Filed: Apr 11, 2025 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | S-1 |
| Filed Date | Apr 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, sec-filing, biotechnology
TL;DR
BiomX filed an S-1, looks like they're raising capital soon.
AI Summary
BiomX Inc. filed an S-1 registration statement on April 11, 2025, to register securities. The company, formerly known as Chardan Healthcare Acquisition Corp. until April 30, 2018, is based in Ness Ziona, Israel, and operates in the biological products sector. The filing indicates a potential offering of securities, though specific dollar amounts and dates for the offering are not detailed in this initial S-1 document.
Why It Matters
This S-1 filing signals BiomX Inc.'s intent to potentially offer new securities to the public, which could impact its capital structure and future growth plans.
Risk Assessment
Risk Level: medium — S-1 filings often precede capital raises, which can be dilutive or indicate financial needs, but the specific details of the offering are not yet public.
Key Numbers
- 333-286496 — SEC File Number (Identifies the specific SEC registration)
- 0001739174 — Central Index Key (Unique identifier for BiomX Inc. in SEC filings)
Key Players & Entities
- BiomX Inc. (company) — Registrant
- Chardan Healthcare Acquisition Corp. (company) — Former company name
- 20180430 (date) — Date of name change
- 20250411 (date) — Filing date
- Jonathan Solomon (person) — Chief Executive Officer
- Haynes and Boone, LLP (company) — Legal counsel
FAQ
What is the purpose of this S-1 filing for BiomX Inc.?
The S-1 filing is a registration statement required by the SEC before a company can offer its securities to the public.
When was BiomX Inc. previously known by another name?
BiomX Inc. was formerly known as Chardan Healthcare Acquisition Corp. until April 30, 2018.
Who is the Chief Executive Officer of BiomX Inc.?
Jonathan Solomon is the Chief Executive Officer of BiomX Inc.
What is the principal executive office address for BiomX Inc.?
The principal executive offices are located at 22 Einstein St., Floor 4, Ness Ziona, Israel, 7414003.
What is the SEC file number associated with this registration statement?
The SEC file number for this registration statement is 333-286496.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on April 11, 2025 by Jonathan Solomon regarding BiomX Inc. (PHGE).